X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (30015) 30015
Newspaper Article (901) 901
Newsletter (371) 371
Book Chapter (226) 226
Dissertation (48) 48
Magazine Article (33) 33
Web Resource (9) 9
Trade Publication Article (8) 8
Publication (7) 7
Reference (6) 6
Conference Proceeding (5) 5
Book / eBook (3) 3
Book Review (2) 2
Streaming Video (2) 2
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (19423) 19423
life sciences & biomedicine (17866) 17866
animals (16892) 16892
male (12952) 12952
humans (11369) 11369
adenosine (8095) 8095
rats (7865) 7865
female (6983) 6983
adenosine triphosphate - metabolism (4569) 4569
mice (4154) 4154
cardiovascular system & cardiology (3331) 3331
middle aged (3119) 3119
neurosciences (3028) 3028
pharmacology & pharmacy (3023) 3023
neurosciences & neurology (2866) 2866
dose-response relationship, drug (2782) 2782
cardiac & cardiovascular systems (2771) 2771
adenosine triphosphatase (2747) 2747
proteins (2664) 2664
physiology (2654) 2654
adult (2593) 2593
rats, sprague-dawley (2512) 2512
research (2491) 2491
abridged index medicus (2458) 2458
adenosine - pharmacology (2405) 2405
adenosine triphosphate (2398) 2398
rodents (2292) 2292
time factors (2281) 2281
aged (2174) 2174
cell biology (2170) 2170
rats, wistar (2103) 2103
physiological aspects (2102) 2102
analysis (2094) 2094
biochemistry & molecular biology (2029) 2029
adenosine - administration & dosage (1922) 1922
adenosine - analogs & derivatives (1894) 1894
kinases (1855) 1855
research article (1840) 1840
disease models, animal (1784) 1784
apoptosis (1695) 1695
medicine (1685) 1685
metabolism (1663) 1663
in vitro techniques (1651) 1651
atp (1598) 1598
science & technology - other topics (1506) 1506
gene expression (1505) 1505
multidisciplinary sciences (1437) 1437
health aspects (1426) 1426
adenosine triphosphate - pharmacology (1400) 1400
enzymes (1398) 1398
signal transduction (1375) 1375
inflammation (1345) 1345
cells, cultured (1326) 1326
oncology (1312) 1312
adenosine triphosphatases - metabolism (1272) 1272
mitochondria (1267) 1267
platelet aggregation - drug effects (1262) 1262
care and treatment (1243) 1243
ischemia (1228) 1228
science (1227) 1227
peripheral vascular disease (1226) 1226
phosphorylation (1225) 1225
oxidative stress (1224) 1224
studies (1197) 1197
mice, inbred c57bl (1192) 1192
adenosine diphosphate - pharmacology (1157) 1157
treatment outcome (1155) 1155
adenosine diphosphate (1147) 1147
cancer (1103) 1103
cardiology (1067) 1067
adenosine - metabolism (1062) 1062
calcium - metabolism (1023) 1023
medicine, research & experimental (1010) 1010
research & experimental medicine (1007) 1007
myocardium - metabolism (1001) 1001
biochemistry (998) 998
nitric oxide (992) 992
hematology (986) 986
dogs (983) 983
medicine & public health (959) 959
diabetes (954) 954
liver - metabolism (945) 945
rabbits (937) 937
endocrinology & metabolism (931) 931
neurology (929) 929
brain (928) 928
surgery (917) 917
biology (907) 907
rats, inbred strains (898) 898
pharmacology (897) 897
immunology (890) 890
patients (878) 878
chemistry (874) 874
blood pressure - drug effects (860) 860
biomedicine (853) 853
glucose (849) 849
liver (849) 849
drug therapy (848) 848
medical research (839) 839
physical sciences (834) 834
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30849) 30849
Japanese (345) 345
Russian (296) 296
German (178) 178
French (78) 78
Chinese (77) 77
Italian (53) 53
Spanish (53) 53
Portuguese (52) 52
Polish (34) 34
Ukrainian (28) 28
Korean (12) 12
Czech (10) 10
Dutch (9) 9
Slovak (9) 9
Hungarian (7) 7
Swedish (6) 6
Turkish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Danish (2) 2
Norwegian (2) 2
Persian (2) 2
Serbian (2) 2
Afrikaans (1) 1
Finnish (1) 1
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2011, Volume 58, Issue 22, pp. 2263 - 2269
Chronic kidney disease (CKD) is prevalent and affects an ever-increasing proportion of patients presenting with acute coronary syndrome (ACS). Patients with... 
Cardiovascular | Internal Medicine | non–ST-segment elevation myocardial infarction | chronic kidney disease | bleeding | ST-segment elevation myocardial infarction | unstable angina | acute coronary syndrome(s) | antiplatelet | antithrombotic | nonST-segment elevation myocardial infarction | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Piperazines - administration & dosage | Prasugrel Hydrochloride | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Heparin - administration & dosage | Thiophenes - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Acute Coronary Syndrome - complications | Aspirin - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Polysaccharides - administration & dosage | Kidney Diseases - complications | Platelet Aggregation Inhibitors - adverse effects | Peptide Fragments - administration & dosage | Polysaccharides - adverse effects | Clinical Trials as Topic | Uremia - complications | Adenosine - administration & dosage | Piperazines - adverse effects | Recombinant Proteins - administration & dosage | Ticlopidine - analogs & derivatives | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Hirudins - adverse effects | Fibrinolytic Agents - administration & dosage | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Chronic Disease | Care and treatment | Chronic kidney failure | Cardiac patients | Cardiology | Coronary heart disease | Health aspects | Cardiovascular agents | Medical colleges | Mortality | Heart attacks | Drug therapy | Acute coronary syndromes | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, ISSN 0363-6119, 10/2009, Volume 297, Issue 4, pp. 1095 - 1102
Journal Article
Canadian journal of cardiology, ISSN 0828-282X, 2013, Volume 29, Issue 11, pp. 1334 - 1345
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 08/2012, Volume 69, Issue 3, pp. 477 - 487
.... Co-administration of ticagrelor with each statin was well tolerated. Exposure to ticagrelor and its active metabolite, AR-C124910XX, was generally unchanged by a single dose of either statin, except for a minor increase in ticagrelor... 
Co-administration | AZD6140 | Biomedicine | Simvastatin | Atorvastatin | Pharmacology/Toxicology | Ticagrelor | Pharmacokinetics | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Adenosine - pharmacokinetics | Purinergic P2Y Receptor Antagonists - administration & dosage | Pyrroles - pharmacokinetics | Simvastatin - adverse effects | Area Under Curve | Heptanoic Acids - pharmacokinetics | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - blood | Half-Life | Male | Metabolic Clearance Rate | Heptanoic Acids - adverse effects | Simvastatin - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Interactions | Pyrroles - administration & dosage | Adenosine - adverse effects | Biotransformation | Platelet Aggregation Inhibitors - administration & dosage | Heptanoic Acids - administration & dosage | Pyrroles - adverse effects | Adult | Female | Platelet Aggregation Inhibitors - pharmacokinetics | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Drug Administration Schedule | Simvastatin - administration & dosage | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Linear Models | Pyrroles - blood | Simvastatin - pharmacokinetics | Adenosine - administration & dosage | Cross-Over Studies | Atorvastatin Calcium | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Adenosine - analogs & derivatives | Least-Squares Analysis | Heptanoic Acids - blood | Dosage and administration | Metabolites | Drug interactions | Antilipemic agents | Drug therapy | Pharmacology | Kinetics | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 07/2009, Volume 106, Issue 30, pp. 12489 - 12493
Journal Article
Pharmacotherapy, ISSN 0277-0008, 05/2020, Volume 40, Issue 5, pp. 416 - 437
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19)... 
dialysis | renal | antivirals | cytochrome P450 | infectious disease | liver | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pandemics | Alanine - adverse effects | Adrenal Cortex Hormones | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Thiazoles - administration & dosage | Hydroxychloroquine - adverse effects | Thiazoles - adverse effects | Alanine - analogs & derivatives | Alanine - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Ritonavir - adverse effects | Ribavirin - administration & dosage | Betacoronavirus | Antibodies, Monoclonal, Humanized - adverse effects | Ritonavir - administration & dosage | Immunomodulation | Azetidines - adverse effects | Chloroquine - adverse effects | Antiviral Agents - administration & dosage | Adenosine Monophosphate - adverse effects | Hydroxychloroquine - administration & dosage | Nelfinavir - adverse effects | Interferon-alpha - administration & dosage | Azetidines - administration & dosage | Ribavirin - adverse effects | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Antiviral Agents - adverse effects | Coronavirus Infections - therapy | Immunization, Passive | Lopinavir - administration & dosage | Sulfonamides - adverse effects | Chloroquine - administration & dosage | Interferon-alpha - adverse effects | Nelfinavir - administration & dosage | Drug Combinations | Lopinavir - adverse effects | Sulfonamides - administration & dosage | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Antiviral agents | Therapeutic applications | Clinical trials | Coronaviruses | Drug therapy | Patients | Index Medicus | Reviews of Therapeutics | Review of Therapeutics
Journal Article